… G6’s wholly-owned subsidiary, Graphene Laboratories Inc. (“Graphene Laboratories” or “GL”), has entered into a License and Option Agreement (the “Agreement”) with a US-based clinical-stage biopharmaceutical company (the “Partner”).
… G6’s wholly-owned subsidiary, Graphene Laboratories Inc. (“Graphene Laboratories” or “GL”), has entered into a License and Option Agreement (the “Agreement”) with a US-based clinical-stage biopharmaceutical company (the “Partner”).